213 related articles for article (PubMed ID: 27836099)
1. [Management of cardiogenic shock: Results from a survey in France and Belgium].
Champion S; Deye N
Ann Cardiol Angeiol (Paris); 2017 Apr; 66(2):59-65. PubMed ID: 27836099
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic support in cardiogenic shock.
Rude RE
Adv Shock Res; 1983; 10():35-49. PubMed ID: 6349299
[TBL] [Abstract][Full Text] [Related]
3. The effects of Levosimendan on global haemodynamics in patients with cardiogenic shock.
Rokyta R; Pechman V
Neuro Endocrinol Lett; 2006; 27(1-2):121-7. PubMed ID: 16648778
[TBL] [Abstract][Full Text] [Related]
4. Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study.
Levy B; Perez P; Perny J; Thivilier C; Gerard A
Crit Care Med; 2011 Mar; 39(3):450-5. PubMed ID: 21037469
[TBL] [Abstract][Full Text] [Related]
5. Predictors of survival in unselected patients with acute myocardial infarction requiring continuous catecholamine support.
Schreiber W; Herkner H; Koreny M; Bur A; Hirschl MM; Glogar D; Huber K; Laggner AN
Resuscitation; 2002 Dec; 55(3):269-76. PubMed ID: 12458064
[TBL] [Abstract][Full Text] [Related]
6. Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine.
El Mokhtari NE; Arlt A; Meissner A; Lins M
Eur J Med Res; 2007 Nov; 12(11):563-7. PubMed ID: 18024265
[TBL] [Abstract][Full Text] [Related]
7. Inotropic agents in the treatment of cardiogenic shock.
Bourdarias JP; Dubourg O; Gueret P; Ferrier A; Bardet J
Pharmacol Ther; 1983; 22(1):53-79. PubMed ID: 6361798
[No Abstract] [Full Text] [Related]
8. Recommendations for the treatment of patients with septic shock.
Meier-Hellmann A; Reinhart K
Acta Anaesthesiol Scand Suppl; 1997; 111():177-80. PubMed ID: 9421002
[No Abstract] [Full Text] [Related]
9. Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics.
García-González MJ; Domínguez-Rodríguez A; Ferrer-Hita JJ; Abreu-González P; Muñoz MB
Eur J Heart Fail; 2006 Nov; 8(7):723-8. PubMed ID: 16492404
[TBL] [Abstract][Full Text] [Related]
10. Essential lessons in cardiogenic shock: epinephrine versus norepinephrine/dobutamine.
Krenn L; Delle Karth G
Crit Care Med; 2011 Mar; 39(3):583-4. PubMed ID: 21330855
[No Abstract] [Full Text] [Related]
11. Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.
Mathew R; Di Santo P; Jung RG; Marbach JA; Hutson J; Simard T; Ramirez FD; Harnett DT; Merdad A; Almufleh A; Weng W; Abdel-Razek O; Fernando SM; Kyeremanteng K; Bernick J; Wells GA; Chan V; Froeschl M; Labinaz M; Le May MR; Russo JJ; Hibbert B
N Engl J Med; 2021 Aug; 385(6):516-525. PubMed ID: 34347952
[TBL] [Abstract][Full Text] [Related]
12. Network Meta-Analysis of the Safety of Drug Therapy for Cardiogenic Shock.
Liao X; Qian L; Zhang S; Chen X; Lei J
J Healthc Eng; 2020; 2020():8862256. PubMed ID: 32802302
[TBL] [Abstract][Full Text] [Related]
13. Extensive variability in vasoactive agent therapy: a nationwide survey in Chinese intensive care units.
Pei XB; Ma PL; Li JG; Du ZH; Zhou Q; Lu ZH; Yun L; Hu B
Chin Med J (Engl); 2015 Apr; 128(8):1014-20. PubMed ID: 25881592
[TBL] [Abstract][Full Text] [Related]
14. Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality.
Tarvasmäki T; Lassus J; Varpula M; Sionis A; Sund R; Køber L; Spinar J; Parissis J; Banaszewski M; Silva Cardoso J; Carubelli V; Di Somma S; Mebazaa A; Harjola VP;
Crit Care; 2016 Jul; 20(1):208. PubMed ID: 27374027
[TBL] [Abstract][Full Text] [Related]
15. Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction.
Levy B; Clere-Jehl R; Legras A; Morichau-Beauchant T; Leone M; Frederique G; Quenot JP; Kimmoun A; Cariou A; Lassus J; Harjola VP; Meziani F; Louis G; Rossignol P; Duarte K; Girerd N; Mebazaa A; Vignon P;
J Am Coll Cardiol; 2018 Jul; 72(2):173-182. PubMed ID: 29976291
[TBL] [Abstract][Full Text] [Related]
16. Role of medical management of cardiogenic shock in the era of mechanical circulatory support.
Blumer V; Marbach J; Veasey T; Kanwar M
Curr Opin Cardiol; 2022 May; 37(3):250-260. PubMed ID: 35612937
[TBL] [Abstract][Full Text] [Related]
17. Comparison of haemodynamic responses to dobutamine and salbutamol in cardiogenic shock after acute myocardial infarction.
Fowler MB; Timmis AD; Crick JP; Vincent R; Chamberlain DA
Br Med J (Clin Res Ed); 1982 Jan; 284(6309):73-6. PubMed ID: 6797661
[TBL] [Abstract][Full Text] [Related]
18. [Use of vasopressors and inotropics in cardiogenic shock].
Lemm H; Dietz S; Janusch M; Buerke M
Herz; 2017 Feb; 42(1):3-10. PubMed ID: 28101622
[TBL] [Abstract][Full Text] [Related]
19. Cardiogenic shock.
Rackley CE; Russell RO; Mantle JA; Rogers WJ
Cardiovasc Clin; 1981; 11(3):15-24. PubMed ID: 7214388
[TBL] [Abstract][Full Text] [Related]
20. The medical treatment of cardiogenic shock: cardiovascular drugs.
De Backer D; Arias Ortiz J; Levy B
Curr Opin Crit Care; 2021 Aug; 27(4):426-432. PubMed ID: 33797431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
